Riding the pepTIDE — The Daily Wire on Therapeutic Peptides

An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.

Topic Sections

  • Top Shots — The most significant peptide and longevity stories ranked by overall editorial score
  • Research Signals — High-credibility scientific findings from journals, preprints, and clinical sources
  • Healing & Recovery — Tissue repair, injury recovery, and gut healing peptides including BPC-157 and TB-500
  • Growth Hormone Wire — Growth hormone secretagogues, peptide stacks, and GH axis research including Ipamorelin, CJC-1295, and MK-677
  • Metabolic & GLP-1 — Metabolic health, insulin sensitivity, and GLP-1 receptor agonist research including semaglutide and tirzepatide
  • Cognitive / Nootropic — Peptides targeting brain function, memory, neuroprotection, and cognitive enhancement
  • Skin & Cosmetic — Skin repair, anti-aging, collagen synthesis, and cosmetic peptide research including GHK-Cu and matrixyl
  • Reddit Finds — Community-sourced discussions, self-experimentation reports, and protocol threads from peptide communities
  • Contrarian Takes — Alternative viewpoints, dissenting research, and perspectives that challenge mainstream peptide narratives
  • Skeptic's Corner — Hype debunking, low-evidence alerts, and critical analysis of overstated peptide claims

Browse by Filter

  • Newest — Latest peptide and longevity stories
  • Most Credible — Highest credibility-scored stories
  • Most Edgy — High-novelty, unconventional findings
  • Most Discussed — Trending community discussions
  • Most Actionable — Direct applicability to daily health protocols
  • Lowest Risk — Stories with strong evidence, low hype
  • Research Only — Peer-reviewed and preprint studies
  • Reddit Only — Community discussion and anecdote
  • GLP-1 / Metabolic — Semaglutide, tirzepatide, and metabolic peptides
  • Healing / Recovery — BPC-157, TB-500, and repair protocols

More

  • About Riding the pepTIDE
  • Health Disclaimer
  • Submit a Source
  • Contact

Mounjaro Makes Eating Hard; Nutrient-Rich Broth Keeps One Patient Going

Someone on a public forum wrote that they’ve been taking Mounjaro (a prescription diabetes and weight-loss drug) since December 2025, increased their dose to 7.5 mg at the end of May, and have lost 22 pounds since the increase. They say they’re having trouble eating solid food at this dose, so they’ve been sipping nutrient-rich broths (they mentioned Brodo, a commercial bone-broth brand) because liquids are easier to keep down. They warn it’s probably high in salt and not right for everyone, but it’s helping them survive. Mounjaro is the brand name for tirzepatide, a medicine that acts like certain gut hormones that tell your brain you’re full and help control blood sugar. In everyday terms: it makes you feel less hungry and slows how quickly your stomach empties, which can cut down how much you eat. People use it for type 2 diabetes and, increasingly, for weight loss. At higher doses some people report strong appetite suppression and sometimes nausea or trouble eating solid meals. The write-up is a single-person report, not a controlled study. It’s an anecdote: one person’s experience over a few months. Their main points are dose increase, notable weight loss (22 pounds), continued poor appetite for solids, and switching to nutrient-rich broths to meet calorie and protein needs. Anecdotes like this are common with tirzepatide and similar drugs — many people see big weight loss and also report nausea, early fullness, or preference for liquids — but this message doesn’t tell us how typical the experience is, how long the broth strategy will work, or whether their weight loss is healthy or supervised by a clinician. Why this matters: a lot of people are trying these medications and want practical ways to cope with side effects. If solids feel unappealing, nutrient-dense broths can be an easier way to get calories, protein, and electrolytes. That can help prevent unintended weight loss, low energy, or nutrient shortfalls while someone adjusts to a new dose. It’s also a reminder that medication effects vary a lot between people, and small lifestyle hacks can make a big difference in comfort and adherence. Important cautions: this is one person’s story, not medical advice. Broths can be high in sodium (salt), so they may not be safe for people with high blood pressure, kidney problems, or heart failure unless a doctor says it’s okay. Tirzepatide can cause nausea, vomiting, or severe appetite loss for some people; if you can’t keep down enough food or fluids, that’s a reason to call your clinician. Never change your dose on your own, and discuss strategies for getting nutrition with your prescriber or a dietitian. Regulatory status and recommended doses depend on the country and the condition being treated; check with a medical professional for your situation. Bottom line: one person on tirzepatide found broths helped them eat when solids were intolerable, but this is an individual report and anyone on these drugs should talk to their clinician before trying similar workarounds.

Source: r/Mounjaro

Read full story

Back to Riding the pepTIDE